Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€13.53
30.03.20
€29.00
04.11.21
72.28%
05.11.21

buy
GW Pharmaceuticals plc ADR

Start price
Target price
Perf. (%)
€80.50
24.03.20
€180.00
04.11.21
127.33%
24.06.21

buy
QIAGEN NV

Start price
Target price
Perf. (%)
€35.52
23.03.20
€47.00
13.10.20
24.97%
13.10.20

buy
Amarin Corp. ADR

Start price
Target price
Perf. (%)
€9.75
21.03.20
€20.00
04.04.20
-55.28%
04.04.20

buy
QIAGEN NV

Start price
Target price
Perf. (%)
€35.99
20.03.20
€41.50
04.11.21
33.34%
05.11.21

Could be worthwhile Investment >10% per year
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€14.80
17.03.20
€16.00
04.11.21
0.00%
06.01.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Small cyclical dependencies
Top 10 in its market
buy
GW Pharmaceuticals plc ADR

Start price
Target price
Perf. (%)
€93.00
28.02.20
€180.00
09.03.20
-15.05%
09.03.20

buy
Perrigo Co. plc

Start price
Target price
Perf. (%)
€45.40
28.02.20
€50.00
04.11.21
-11.45%
05.11.21

Could be worthwhile Investment >10% per year
Small cyclical dependencies
Known brand
Top 10 in its market
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€33.90
27.02.20
€43.00
04.11.21
41.56%
05.11.21

buy
MorphoSys AG

Start price
Target price
Perf. (%)
€106.70
25.02.20
€61.00
04.11.21
-61.92%
05.11.21

positive Cash Flow expected
Good rating
High Investments for future growth
High valuation
buy
Evotec SE

Start price
Target price
Perf. (%)
€26.01
13.02.20
€35.00
04.11.21
27.91%
27.02.21

Revenue growth >5% per year expected
Fair valuation
Capable Management
buy
LivaNova plc

Start price
Target price
Perf. (%)
€62.50
28.01.20
€100.00
04.11.21
-34.40%
09.11.20

buy
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€50.50
28.01.20
€55.00
04.11.21
-23.09%
05.11.21

Could be worthwhile Investment >10% per year
buy
Repligen Corp.

Start price
Target price
Perf. (%)
€87.50
12.01.20
€155.00
04.11.21
170.06%
05.11.21

Could be worthwhile Investment >10% per year
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€18.00
21.12.19
€30.00
04.11.21
-36.06%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€109.44
27.11.19
-
04.11.21
65.25%
16.10.21

Could be worthwhile Investment >10% per year
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€4.29
25.11.19
-
04.11.21
196.12%
05.11.21

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
buy
Myokardia Inc

Start price
Target price
Perf. (%)
€48.80
13.11.19
€202.00
04.11.21
291.39%
05.11.21

buy
Evotec SE

Start price
Target price
Perf. (%)
€19.29
12.11.19
€44.00
29.10.24
-25.95%
27.02.24

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€36.04
13.09.19
€60.00
02.10.19
-9.27%
02.10.19

buy
Horizon Pharma plc

Start price
Target price
Perf. (%)
€24.60
26.08.19
€69.00
04.11.21
284.63%
05.11.21

buy
Evotec SE

Start price
Target price
Perf. (%)
€19.10
15.08.19
€35.00
04.11.21
105.76%
05.11.21

buy
Swedish Orphan Biovitrum Ab

Start price
Target price
Perf. (%)
€19.49
17.07.19
€30.00
04.11.21
20.11%
05.11.21

buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€35.31
10.06.19
€63.14
04.11.21
-36.68%
01.07.21

buy
Penumbra Inc

Start price
Target price
Perf. (%)
€144.32
10.06.19
€148.83
10.06.19
3.43%
10.06.19